Reference
Bednarek R, et al. Eruptive keratoacanthomas secondary to nivolumab immunotherapy. International Journal of Dermatology 57: e28-e29, No. 3, Mar 2018. Available from: URL: http://doi.org/10.1111/ijd.13893 - USA
Rights and permissions
About this article
Cite this article
Nivolumab. Reactions Weekly 1694, 323 (2018). https://doi.org/10.1007/s40278-018-43724-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-43724-4